[go: up one dir, main page]

PL3744316T3 - Okulistyczna kompozycja farmaceutyczna, sposób jej wytwarzania i zastosowanie - Google Patents

Okulistyczna kompozycja farmaceutyczna, sposób jej wytwarzania i zastosowanie

Info

Publication number
PL3744316T3
PL3744316T3 PL19743390.7T PL19743390T PL3744316T3 PL 3744316 T3 PL3744316 T3 PL 3744316T3 PL 19743390 T PL19743390 T PL 19743390T PL 3744316 T3 PL3744316 T3 PL 3744316T3
Authority
PL
Poland
Prior art keywords
preparation
application
pharmaceutical composition
method therefor
ophthalmic pharmaceutical
Prior art date
Application number
PL19743390.7T
Other languages
English (en)
Inventor
Zuguo LIU
Yufen Zhao
Caihong HUANG
Yang Wu
Guo Tang
Yan Liu
Pengxiang XU
Original Assignee
Seinda Pharmaceutical Guangzhou Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seinda Pharmaceutical Guangzhou Corporation filed Critical Seinda Pharmaceutical Guangzhou Corporation
Publication of PL3744316T3 publication Critical patent/PL3744316T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05Dipeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/04Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Dispersion Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL19743390.7T 2018-01-23 2019-01-22 Okulistyczna kompozycja farmaceutyczna, sposób jej wytwarzania i zastosowanie PL3744316T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201810063904.7A CN108785251B (zh) 2018-01-23 2018-01-23 一种眼用药物组合物及其制备方法和应用
PCT/CN2019/072664 WO2019144863A1 (zh) 2018-01-23 2019-01-22 一种眼用药物组合物及其制备方法和应用

Publications (1)

Publication Number Publication Date
PL3744316T3 true PL3744316T3 (pl) 2024-04-15

Family

ID=64094622

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19743390.7T PL3744316T3 (pl) 2018-01-23 2019-01-22 Okulistyczna kompozycja farmaceutyczna, sposób jej wytwarzania i zastosowanie

Country Status (22)

Country Link
US (2) US20210030833A1 (pl)
EP (2) EP4279063A3 (pl)
JP (2) JP7418351B2 (pl)
KR (2) KR20240126076A (pl)
CN (2) CN108785251B (pl)
AU (2) AU2019212565B2 (pl)
BR (1) BR112020014950A2 (pl)
CA (1) CA3089344A1 (pl)
DK (1) DK3744316T3 (pl)
ES (1) ES2960069T3 (pl)
FI (1) FI3744316T3 (pl)
HR (1) HRP20231069T1 (pl)
HU (1) HUE063566T2 (pl)
IL (1) IL276244B2 (pl)
LT (1) LT3744316T (pl)
PL (1) PL3744316T3 (pl)
PT (1) PT3744316T (pl)
RS (1) RS64732B1 (pl)
SG (1) SG11202007077YA (pl)
SI (1) SI3744316T1 (pl)
SM (1) SMT202300350T1 (pl)
WO (1) WO2019144863A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7274475B2 (ja) 2017-07-20 2023-05-16 セインダ ファーマシューティカル グアンジョウ コーポレイション 近視の処置のための組成物および方法
CN108785251B (zh) * 2018-01-23 2020-11-24 盛元医药广州有限公司 一种眼用药物组合物及其制备方法和应用
CN109771370B (zh) 2019-02-28 2021-03-30 厦门大学 一种眼内手术用前房灌注液及其用途
CN113171340B (zh) * 2021-05-07 2022-12-06 四川科伦药业股份有限公司 一种丙氨酰谷氨酰胺注射液及其生产工艺
JP2024542280A (ja) * 2021-12-01 2024-11-13 セインダ ファーマシューティカル グアンジョウ コーポレイション アラニル-グルタミンおよびアラニル-グルタミンを含む眼科用組成物の新規な使用
CN114869873A (zh) * 2022-05-05 2022-08-09 陈小鸟 谷氨酰胺在制备治疗干眼症的药物中的应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3206784C2 (de) * 1982-02-25 1985-05-09 Pfrimmer & Co Pharmazeutische Werke Erlangen Gmbh, 8520 Erlangen Glutaminhaltige Zubereitungen für orale oder intravenöse Applikation
DE59103389D1 (de) * 1990-05-04 1994-12-08 Ciba Geigy Ag Substituierte Indole.
EP0539329A1 (de) * 1991-10-25 1993-04-28 Ciba-Geigy Ag Acetylen-Verbindungen, verwendbar als Leukotrien-Antagonisten
GB9419011D0 (en) * 1994-09-21 1994-11-09 Peptech Uk Ltd Use of muramyl peptide compounds
WO2002090380A1 (en) * 2001-04-17 2002-11-14 Sankt-Peterburgskaya Obschestvennaya Organizatsiya 'institut Bioregulyatsii I Gerontologii Czo Ramn' Tetrapeptide stimulating the retinal function and the method of its application
WO2004028536A1 (en) * 2002-09-30 2004-04-08 Babizhayev Mark A Method for topical treatment of eye disease and composition and device for said treatment
WO2005030243A1 (en) * 2003-09-26 2005-04-07 Bristol Myers Squibb Company Arginyl-glutamine dipeptide for treatment of pathological vascular proliferation
US8697154B2 (en) * 2007-03-05 2014-04-15 Om Pharma Sa Bacterial extract for respiratory disorders and process for its preparation
US8629099B2 (en) * 2008-03-25 2014-01-14 Bausch & Lomb Incorporated Ophthalmic compositions comprising a dipeptide
WO2010107069A1 (ja) * 2009-03-17 2010-09-23 千寿製薬株式会社 アミノ酸含有眼科用組成物
JP5716018B2 (ja) * 2009-09-16 2015-05-13 千寿製薬株式会社 ラクリチンの部分ペプチド
JP5911503B2 (ja) * 2010-11-15 2016-04-27 ラモット・アット・テル・アビブ・ユニバーシテイ・リミテッドRamot At Tel Aviv University Ltd. アミロイド線維形成関連状態を処置するためのジペプチドアナログ
US20130225684A1 (en) * 2012-02-28 2013-08-29 Kyowa Hakko Bio Co., Ltd. Methods and compositions for enhancement of vision performance
RU2498570C1 (ru) * 2012-05-03 2013-11-20 Государственное бюджетное учреждение "Уфимский научно-исследовательский институт глазных болезней Академии наук Республики Башкортостан" Раствор для хранения роговицы
WO2016134498A1 (en) * 2015-02-25 2016-09-01 Tsung-Chuan Ho Use of short synthetic peptide for the treatment and/or prophylaxis of dry eye disease
CN107049938B (zh) * 2017-05-11 2021-01-05 艾迈德(厦门)生物科技有限公司 一种用于治疗干眼的滴眼液
CN108785251B (zh) * 2018-01-23 2020-11-24 盛元医药广州有限公司 一种眼用药物组合物及其制备方法和应用

Also Published As

Publication number Publication date
EP3744316A1 (en) 2020-12-02
CN112516080B (zh) 2023-09-19
KR20200113243A (ko) 2020-10-06
RU2020127883A (ru) 2022-02-24
SI3744316T1 (sl) 2024-01-31
EP3744316A4 (en) 2021-12-08
CN108785251B (zh) 2020-11-24
CN108785251A (zh) 2018-11-13
AU2019212565A1 (en) 2020-08-13
ES2960069T3 (es) 2024-02-29
US20240148818A1 (en) 2024-05-09
EP3744316B1 (en) 2023-08-30
AU2024216339A1 (en) 2024-09-19
JP2021512172A (ja) 2021-05-13
IL276244A (en) 2020-09-30
JP2024045187A (ja) 2024-04-02
EP4279063A2 (en) 2023-11-22
IL276244B1 (en) 2024-08-01
HRP20231069T1 (hr) 2023-12-22
LT3744316T (lt) 2023-11-10
CN112516080A (zh) 2021-03-19
SMT202300350T1 (it) 2023-11-13
EP4279063A3 (en) 2024-02-14
SG11202007077YA (en) 2020-08-28
FI3744316T3 (fi) 2023-09-12
WO2019144863A1 (zh) 2019-08-01
AU2019212565B2 (en) 2024-06-06
US20210030833A1 (en) 2021-02-04
DK3744316T3 (da) 2023-10-16
HUE063566T2 (hu) 2024-01-28
KR20240126076A (ko) 2024-08-20
IL276244B2 (en) 2024-12-01
CA3089344A1 (en) 2019-08-01
JP7418351B2 (ja) 2024-01-19
PT3744316T (pt) 2023-09-20
KR102696573B1 (ko) 2024-08-19
RS64732B1 (sr) 2023-11-30
BR112020014950A2 (pt) 2020-12-08

Similar Documents

Publication Publication Date Title
SG11202105850YA (en) Diphenyl-like compound, intermediate thereof, preparation method therefor, pharmaceutical composition thereof and uses thereof
EP3725798A4 (en) BIOACTIVE CONJUGATE, METHOD FOR ITS MANUFACTURING AND USES
HK1255566A1 (zh) 氧代吡啶酰胺類衍生物、其製備方法及其在醫藥上的應用
SG11202006409TA (en) Biaryl derivative, preparation method therefor and pharmaceutical use thereof
EP3453707A4 (en) BENZAZEPINE DERIVATIVE, MANUFACTURING PROCESS, PHARMACEUTICAL COMPOSITION AND USE THEREOF
IL276244A (en) A pharmaceutical preparation for the eyes, a method for its preparation and its application
EP3636646A4 (en) HETEROARYL PYRAZOL DERIVATIVE AND MANUFACTURING METHOD FOR IT AND MEDICAL USES THEREOF
EP3491026A4 (en) HUMAN ANTIBODIES, PHARMACEUTICAL COMPOSITIONS AND METHODS
EP3251698A4 (en) Ligand-cytotoxicity drug conjugate, preparing method therefor, and application thereof
EP3673897A4 (en) INJECTABLE PHARMACEUTICAL COMPOSITION WITH MELOXICAM AND METHOD FOR MANUFACTURING IT
EP3130354A4 (en) Posaconazole pharmaceutical composition and preparation method, application and pharmaceutical preparation thereof
EP3275867A4 (en) Condensed ring derivative, and preparation method, intermediate, pharmaceutical composition and use thereof
IL272446A (en) Penta-condensed hexa-heterocyclic compounds, method for their preparation, drug combination and use thereof
IL270363B2 (en) N-(AZAARYL)CYCLOLACTAM–1–CARBOXAMIDE DERIVATIVE – METHOD FOR ITS PREPARATION AND USE
EP4053152A4 (en) KERATIN BD-13, PRODUCTION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF
EP3604343A4 (en) FUSION PROTEIN, MANUFACTURING METHOD THEREFOR AND USE THEREOF
EP3838265A4 (en) INJECTABLE PHARMACEUTICAL COMPOSITION AND METHOD FOR PREPARATION
EP3858833A4 (en) AMINONORDECANE DERIVATIVE, METHOD FOR PREPARATION AND USE
EP3412286A4 (en) TAXOL MEDICINAL PRODUCT AND PHARMACEUTICAL PREPARATION, METHOD OF MANUFACTURING THEREOF AND USE THEREOF
IL285378A (en) A heterocyclic compound, a medical preparation containing it, a method for its preparation, and its use
EP3650448A4 (en) INDOLE-FORMAMIDE, PROCESS OF PREPARATION AND USE IN MEDICINE
EP3777862A4 (en) COMPOSITION OF MELOXICAM, ITS PREPARATION AND PROCESS OF PREPARATION AND USE
EP3284743A4 (en) Heterocyclic-imidazole compounds, pharmaceutical compositions thereof, preparation method therefor and use thereof
EP3813842A4 (en) PHARMACEUTICAL COMPOSITION AND MANUFACTURING PROCESS THEREOF
EP4053159A4 (en) KERATIN BD-6, PRODUCTION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF